🚫该化合物属于"专利保护",如信息不准确，请联系平台修改
Anlotinib(1058156-90-3)名称与标识符
名称
中文别名：
1-[[[4-[(4-氟-2-甲基-1H-吲哚-5-基)氧基]-6-甲氧基-7-喹啉基]氧基]甲基]环丙胺;安罗替尼;
英文别名：
AL 3818;CS-5396;HY-19716;UNII-GKF8S4C432;NSC-832523;BRD-K36949735-001-01-1;Cyclopropanamine, 1-(((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolinyl)oxy)methyl)-;Cyclopropanamine, 1-[[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-quinolinyl]oxy]methyl]-;NSC832523;1058156-90-3;1-[({4-[(4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY]-6-METHOXYQUINOLIN-7-YL}OXY)METHYL]CYCLOPROPAN-1-AMINE;Anlotinib?;1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropan-amine;Catequentinib (USAN/INN);Anlotinib;GLXC-10628;SB19798;NS00073391;CATEQUENTINIB [USAN];AKOS030526233;catequentinib;CATEQUENTINIB [INN];DB11885;1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinolin-7-yl)oxymethyl)cyclopropan-1-amine;AL3818;GTPL9601;SCHEMBL29379727;ISB15690;D12526;AL-3818;Q27279141;GKF8S4C432;4678B;SCHEMBL29383986;1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxymethyl]cyclopropan-1-amine;1-(((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropan-1-amine;CHEMBL4303201;SCHEMBL2063386;KSMZEXLVHXZPEF-UHFFFAOYSA-N;EX-A2427;CATEQUENTINIB [WHO-DD];C13643;BCP24991;SCHEMBL29364137;1-(((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXY-7-QUINOLINYL)OXY)METHYL)CYCLOPROPANAMINE;Chiglitazar;1-(((4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinolin-7-yl)oxy)methyl)cyclopropanamine;1-[[[4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-quinolinyl]oxy]methyl]cyclopropanamine;
标识符
InChIKey：
KSMZEXLVHXZPEF-UHFFFAOYSA-N
Inchi：
1S/C23H22FN3O3/c1-13-9-15-16(27-13)3-4-19(22(15)24)30-18-5-8-26-17-11-21(20(28-2)10-14(17)18)29-12-23(25)6-7-23/h3-5,8-11,27H,6-7,12,25H2,1-2H3
SMILES：
FC1=C(C=CC2=C1C=C(C)N2)OC1C=CN=C2C=1C=C(C(=C2)OCC1(CC1)N)OC
Anlotinib(1058156-90-3)物化性质
实验特性
- 溶解度 : Insuluble (1.3E-3 g/L) (25 ºC),
- 颜色与性状 : Solid powder
- 密度 : 1.342±0.06 g/cm3 (20 ºC 760 Torr),
计算特性
- 精确分子量 : 407.16451973g/mol
- 氢键供体数量 : 2
- 氢键受体数量 : 6
- 可旋转化学键数量 : 6
- 同位素质量 : 407.16451973g/mol
- 重原子数量 : 30
- 复杂度 : 606
- 同位素原子数量 : 0
- 确定原子立构中心数量 : 0
- 不确定原子立构中心数量 : 0
- 确定化学键立构中心数量 : 0
- 不确定化学键立构中心数量 : 0
- 共价键单元数量 : 1
- 疏水参数计算参考值（XlogP） : 3.7
- 拓扑分子极性表面积 : 82.4Ų
Anlotinib(1058156-90-3)安全信息
Anlotinib(1058156-90-3)推荐厂家 更多厂家(7)
Anlotinib(1058156-90-3)参考资料
2355265332 
![3-[(2-tert-butyl-5-methoxy-1,3-benzothiazol-6-yl)carbamothioylsulfanyl]propanoic acid](http://hg.y866.cn/compound/lib/scimg/cas/150/81059-04-3.png "3-[(2-tert-butyl-5-methoxy-1,3-benzothiazol-6-yl)carbamothioylsulfanyl]propanoic acid")
![[(1aS,1bα,5aα,6aβ)-2α-(β-D-Glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-6α-yl]α-D-galactopyranoside](http://hg.y866.cn/compound/lib/scimg/cas/150/81720-06-1.png "[(1aS,1bα,5aα,6aβ)-2α-(β-D-Glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-6α-yl]α-D-galactopyranoside")
